Literature DB >> 19616740

Clinical radiation sensitivity with DNA repair disorders: an overview.

Julianne M Pollard1, Richard A Gatti.   

Abstract

Adverse reactions to radiotherapy represent a confounding phenomenon in radiation oncology. These reactions are rare, and many have been associated with individuals with DNA repair disorders such as ataxia-telangiectasia and Nijmegen Breakage syndrome. A paucity of published data is available detailing such circumstances. This overview describes four exemplary situations, a comprehensive list of 32 additional cases, and some insights gleaned from this overall experience. Fanconi anemia was associated with more than one-half of the reports. The lowest dose given to a patient that resulted in a reaction was 3 Gy, given to an ataxia-telangiectasia patient. Most patients died within months of exposure. It is clear that the patients discussed in this report had complicated illnesses, in addition to cancer, and the radiotherapy administered was most likely their best option. However, the underlying DNA repair defects make conventional radiation doses dangerous. Our findings support previous wisdom that radiotherapy should either be avoided or the doses should be selected with great care in the case of these radiosensitive genotypes, which must be recognized by their characteristic phenotypes, until more rapid, reliable, and functional assays of DNA repair become available.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616740      PMCID: PMC2725446          DOI: 10.1016/j.ijrobp.2009.02.057

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  76 in total

1.  Medulloblastoma with adverse reaction to radiation therapy in nijmegen breakage syndrome.

Authors:  Sameer Bakhshi; Karen M Cerosaletti; Patrick Concannon; Erawati V Bawle; James Fontanesi; Richard A Gatti; Kanta Bhambhani
Journal:  J Pediatr Hematol Oncol       Date:  2003-03       Impact factor: 1.289

2.  Clinical and cellular radiosensitivity in inherited human syndromes.

Authors:  T Leong; M Borg; M McKay
Journal:  Clin Oncol (R Coll Radiol)       Date:  2004-05       Impact factor: 4.126

Review 3.  Ataxia-telangiectasia, an evolving phenotype.

Authors:  Helen H Chun; Richard A Gatti
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

Review 4.  An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome.

Authors:  M O'Driscoll; A R Gennery; J Seidel; P Concannon; P A Jeggo
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

5.  DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Nature       Date:  2003-01-30       Impact factor: 49.962

6.  Chromosomal fragility syndrome and family history of radiosensitivity as indicators for radiotherapy dose modification.

Authors:  Ghazi Alsbeih; Michael D Story; Moshe H Maor; Fady B Geara; William A Brock
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

7.  Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.

Authors:  Luitpold Distel; Susann Neubauer; Raymonda Varon; Wolfgang Holter; Gerhard Grabenbauer
Journal:  Med Pediatr Oncol       Date:  2003-07

8.  Fanconi's anemia and clinical radiosensitivity report on two adult patients with locally advanced solid tumors treated by radiotherapy.

Authors:  Michael Bremer; Detlev Schindler; Michaela Gross; Thilo Dörk; Susanne Morlot; Johann H Karstens
Journal:  Strahlenther Onkol       Date:  2003-11       Impact factor: 3.621

9.  Vulvar cancer in a patient with Fanconi's anemia, treated with 3D conformal radiotherapy.

Authors:  Jennifer L Harper; Joseph M Jenrette; S Murty Goddu; Asheesh Lal; Tim Smith
Journal:  Am J Hematol       Date:  2004-06       Impact factor: 10.047

10.  Radiation-hypersensitive cancer patients do not manifest protein expression abnormalities in components of the nonhomologous end-joining (NHEJ) pathway.

Authors:  T Leong; M Chao; S Bassal; M McKay
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

View more
  65 in total

1.  Predicting toxicity from radiation therapy--it's genetic, right?

Authors:  Chris R Kelsey; Barry S Rosenstein; Lawrence B Marks
Journal:  Cancer       Date:  2011-12-05       Impact factor: 6.860

2.  A small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown.

Authors:  Geoff S Higgins; Remko Prevo; Yin-Fai Lee; Thomas Helleday; Ruth J Muschel; Steve Taylor; Michio Yoshimura; Ian D Hickson; Eric J Bernhard; W Gillies McKenna
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

3.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

Review 4.  Cancer risks associated with external radiation from diagnostic imaging procedures.

Authors:  Martha S Linet; Thomas L Slovis; Donald L Miller; Ruth Kleinerman; Choonsik Lee; Preetha Rajaraman; Amy Berrington de Gonzalez
Journal:  CA Cancer J Clin       Date:  2012-02-03       Impact factor: 508.702

5.  Radiogenomic Predictors of Adverse Effects following Charged Particle Therapy.

Authors:  Lindsay M Morton; Luisel Ricks-Santi; Catharine M L West; Barry S Rosenstein
Journal:  Int J Part Ther       Date:  2018-09-21

Review 6.  New challenges in high-energy particle radiobiology.

Authors:  M Durante
Journal:  Br J Radiol       Date:  2014-03       Impact factor: 3.039

Review 7.  Establishing the Impact of Vascular Damage on Tumor Response to High-Dose Radiation Therapy.

Authors:  Katherine D Castle; David G Kirsch
Journal:  Cancer Res       Date:  2019-08-19       Impact factor: 12.701

Review 8.  Strong association between cancer and genomic instability.

Authors:  Christian Streffer
Journal:  Radiat Environ Biophys       Date:  2009-12-24       Impact factor: 1.925

9.  Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts.

Authors:  Xiaohua Ni; Yonggang Zhang; Judit Ribas; Wasim H Chowdhury; Mark Castanares; Zhewei Zhang; Marikki Laiho; Theodore L DeWeese; Shawn E Lupold
Journal:  J Clin Invest       Date:  2011-05-09       Impact factor: 14.808

10.  Ovarian cancer and DNA repair: DNA ligase IV as a potential key.

Authors:  Joana Assis; Deolinda Pereira; Rui Medeiros
Journal:  World J Clin Oncol       Date:  2013-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.